Amazon, Eli Lilly On Deck Thursday As AWS Growth, Drug Demand Face Test

Key takeaways

• Amazon’s earnings will decide if AWS can keep accelerating while AI spending stays under control, setting the tone for growth‑heavy stocks this week.
• Amazon revenue 202.22 billion (+12%)
• Amazon
  EPS

  Earnings per share — profit for one share of the company, in dollars.

  Learn more →

  1.97 (+1%)
• Eli Lilly revenue 22.51 billion (+28%)

What happened

Amazon and several other companies are set to report earnings Thursday, with investors watching whether Amazon Web Services can keep growing fast while the company’s heavy spending on artificial intelligence pulls on short‑term margins. The earnings calendar also includes Eli Lilly, Mastercard, Merck, Caterpillar and Shell, all of whom have recently posted strong revenue growth or have new product launches that could lift future earnings.

Why it matters

Amazon’s results will test whether its cloud business can sustain momentum as it ramps up AI investments that could weigh on profitability. The other companies’ reports will confirm whether their recent product launches and market expansions are translating into higher revenue and earnings, which could influence…

Short-term and longer-term

Short-term. Amazon’s stock is likely to react to the earnings release within the next few days.

Longer-term. Over the coming months, Amazon’s ability to grow AWS while managing AI costs will shape its long‑term valuation.